OpenVSafe by OpenVAERS
Search V-safe

7TB-14261-68406

4 vaccinations 4 coded responses 8 check-ins 4 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
024 / MA
Registered
2021-05-02
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-10
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-01
    Dose 2 — Pfizer-BioNTech
  3. 2021-05-02
    Registered in v-safe
  4. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-05-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  6. 2021-05-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  7. 2021-07-31
    Survey response — 3 months, dose 2
    MedDRA: Chills, Headache, Nausea, Oropharyngeal pain, Pain, Pyrexia, Sinus pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: High fever (103F), body aches, chills, sore throat, headache, sinus pain, nausea
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  8. 2021-07-31
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  9. 2021-08-13
  10. 2021-09-09
    Dose 3 — Pfizer-BioNTech
  11. 2022-04-09
    Dose 4 — Moderna
  12. 2022-05-01
    Survey response — 12 months, dose 2
    MedDRA: Cardiac disorder, Condition aggravated, Dyspnoea exertional, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Graves disease relapse, heart issues, dyspnea on exertion
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-05-01
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  14. 2022-05-02
    Health check-in — day 21, dose 4
    Feeling: Fair
    Adult check-in
  15. 2022-05-02
  16. 2022-05-09
    Survey response — day 28, dose 4
    MedDRA: Abdominal discomfort, Chest discomfort, Decreased appetite, Dizziness, Dyspnoea exertional, Fatigue, Gastrointestinal disorder, Headache, Influenza like illness, Nasopharyngitis, Palpitations, Pyrexia, Respiratory tract congestion, Sinus pain, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Cold/flu like symptoms (sinus pain, headache, mild fever, congestion), gastrointestinal (loss of appetite, stomach upset, bowel movement changes), cardiac (palpitations, chest tightness, dyspnea on exertion), general (fatigue, dizziness)
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-10-10
    Survey response — 6 months, dose 4
    MedDRA: Menstrual disorder, Nausea, Vertigo — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Menstrual cycle changes, vertigo, nausea
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-10-10
    Report sent to call center — 6 months, dose 4
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  19. 2022-10-11
  20. 2022-10-11
  21. 2022-10-11

Vaccinations

DoseDateManufacturerCo-administered
12021-04-10Pfizer-BioNTech
22021-05-01Pfizer-BioNTech
32021-09-09Pfizer-BioNTech No
42022-04-09Moderna No

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 9 — 3 months, dose 2

2021-07-31

Symptoms: High fever (103F), body aches, chills, sore throat, headache, sinus pain, nausea

Release 11 — 12 months, dose 2

2022-05-01

Symptoms: Graves disease relapse, heart issues, dyspnea on exertion

Release 11 — day 28, dose 4

2022-05-09

Symptoms: Cold/flu like symptoms (sinus pain, headache, mild fever, congestion), gastrointestinal (loss of appetite, stomach upset, bowel movement changes), cardiac (palpitations, chest tightness, dyspnea on exertion), general (fatigue, dizziness)

Release 12 — 6 months, dose 4

2022-10-10

Symptoms: Menstrual cycle changes, vertigo, nausea

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal discomfort · · ✓
SDCardiac disorder · · ✓
SDChest discomfort · · ✓
SDChills ✓ · ✓
SDCondition aggravated · · ✓
SDDecreased appetite · · ✓
SDDizziness · · ✓
SDDyspnoea exertional · · ✓
SDFatigue · · ✓
SDGastrointestinal disorder · · ✓
SDHeadache ✓ · ✓
SDInfluenza like illness · · ✓
SDMenstrual disorder · · ✓
SDNasopharyngitis · · ✓
SDNausea ✓ · ✓
SDOropharyngeal pain ✓ · ✓
SDPain ✓ · ✓
SDPalpitations · · ✓
SDPre-existing disease · · ✓
SDPyrexia ✓ · ✓
SDRespiratory tract congestion · · ✓
SDSinus pain ✓ · ✓
SDUnevaluable event · · ✓
SDVertigo · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release